Otros idiomas Marinus Pharmaceuticals, Inc.

Acciones

MRNS

US56854Q2003

Farmacéuticos

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 10/02/2025			Variación 5 días	Varia. 1 de enero.
0,5500 ^USD	+0,09 %		-.--%	+2,78 %

07/02	Immedica Pharma AB completó la adquisición de Marinus Pharmaceuticals, Inc. (NasdaqGM:MRNS).	CI
03/01	MARINUS PHARMACEUTICALS, INC. : Truist Securities permanece neutral	ZM

Otros idiomas

Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from S&P TMI Index	12/02
Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from NASDAQ Composite Index	11/02
Immedica Pharma AB completed the acquisition of Marinus Pharmaceuticals, Inc..	07/02
MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS	07/01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders	03/01
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Marinus Pharmaceuticals, Inc. - MRNS	30/12
Sector Update: Health Care Stocks Softer Late Afternoon	30/12
Sector Update: Health Care Stocks Lower Monday Afternoon	30/12
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders	30/12
Sector Update: Health Care	30/12
Shareholder Alert: Ademi LLP Investigates Whether Marinus Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders	30/12
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday	30/12
MRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Marinus Pharmaceuticals, Inc. Is Fair to Shareholders	30/12
Sector Update: Health Care	30/12
Marinus Pharmaceuticals Shares Up Pre-Bell on Deal to Be Acquired by Immedica Pharma for $0.55 a Share	30/12
KKR, Impilo's Immedica Pharma Agrees Purchase of Marinus Pharmaceuticals	30/12
Orion Terminates Drug Distribution Deal With Marinus Pharmaceuticals	30/12
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.	30/12
Orion and Marinus Terminate Agreement for ganaxolone in Europe	30/12
Immedica Pharma AB entered into definitive agreement to acquire Marinus Pharmaceuticals, Inc..	30/12
Immedica Pharma AB entered into an agreement to acquire Marinus Pharmaceuticals, Inc..	30/12
Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from NASDAQ Biotechnology Index	20/12
Marinus Pharmaceuticals : Provides Business Update and Reports Third Quarter 2024 Financial Results Form 8 K	12/11
Marinus Pharmaceuticals : Corporate Overview Slide Deck	12/11
Earnings Flash (MRNS) MARINUS PHARMACEUTICALS Reports Q3 Revenue $8.5M	12/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Marinus Pharmaceuticals, Inc.

Acciones

MRNS

US56854Q2003

Farmacéuticos

Otros idiomas

Filtros